John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Martin Marietta Materials
MLM
$37.8B
| $1.11M | ﹤0.01% |
1,811
| – | – |
|
1852
Sensient Technologies
SXT
$5.82B
| $1.11M | ﹤0.01% |
16,058
-7,423
| -32% | -$481K |
|
1853
Consolidated Water Co
CWCO
$482M
| $1.11M | ﹤0.01% |
+37,878
| New | +$1.16M |
|
1854
Shattuck Labs
STTK
$809M
| $1.11M | ﹤0.01% |
+124,179
| New | +$1.14M |
|
1855
Fastly Inc
FSLY
$3.66B
| $1.11M | ﹤0.01% |
85,513
-848,731
| -91% | -$14.3M |
|
|
OKLO
1856
Oklo
OKLO
$8.24B
| $1.11M | ﹤0.01% |
97,000
| – | – |
|
1857
Invesco NASDAQ Internet ETF
PNQI
$547M
| $1.1M | ﹤0.01% |
+27,700
| New | +$1.06M |
|
1858
Applied Industrial Technologies
AIT
$12.3B
| $1.1M | ﹤0.01% |
5,572
+3,300
| +145% | +$603K |
|
1859
Adtran
ADTN
$653M
| $1.1M | ﹤0.01% |
202,076
+139,113
| +221% | +$887K |
|
1860
NorthWestern Energy
NWE
$4.36B
| $1.1M | ﹤0.01% |
+21,565
| New | +$1.05M |
|
1861
Unifirst Corp
UNF
$5.21B
| $1.1M | ﹤0.01% |
6,330
+5,020
| +383% | +$852K |
|
1862
Smith Douglas Homes
SDHC
$104M
| $1.1M | ﹤0.01% |
+36,922
| New | +$1.04M |
|
|
TDAY
1863
USA Today Co
TDAY
$953M
| $1.09M | ﹤0.01% |
447,924
-292,043
| -39% | -$656K |
|
1864
Verizon
VZ
$209B
| $1.09M | ﹤0.01% |
26,026
+26
| +0.1% | +$1.05K |
|
|
ITOS
1865
DELISTED
iTeos Therapeutics
ITOS
| $1.09M | ﹤0.01% |
80,052
+52,835
| +194% | +$576K |
|
1866
Myers Industries
MYE
$1.23B
| $1.09M | ﹤0.01% |
47,069
-39,348
| -46% | -$778K |
|
|
NXRT
1867
NexPoint Residential Trust
NXRT
$624M
| $1.09M | ﹤0.01% |
+33,859
| New | +$1.05M |
|
1868
WesBanco
WSBC
$3.89B
| $1.09M | ﹤0.01% |
36,537
+29,337
| +407% | +$857K |
|
1869
Trip.com Group
TCOM
$29B
| $1.09M | ﹤0.01% |
24,807
-25,500
| -51% | -$1.04M |
|
|
FFWM
1870
DELISTED
First Foundation Inc
FFWM
| $1.09M | ﹤0.01% |
144,079
+26,384
| +22% | +$226K |
|
1871
Coastal Financial
CCB
$721M
| $1.09M | ﹤0.01% |
27,944
+2,234
| +9% | +$88.4K |
|
1872
Olema Pharmaceuticals
OLMA
$955M
| $1.08M | ﹤0.01% |
95,814
-69,895
| -42% | -$902K |
|
1873
Advanced Energy
AEIS
$11B
| $1.08M | ﹤0.01% |
+10,628
| New | +$1.08M |
|
1874
Artisan Partners
APAM
$3.1B
| $1.08M | ﹤0.01% |
23,680
-28,472
| -55% | -$1.22M |
|
|
HAYN
1875
DELISTED
Haynes International, Inc.
HAYN
| $1.08M | ﹤0.01% |
18,021
-3,678
| -17% | -$212K |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.